---
figid: PMC7463463__cells-09-01904-g001
figtitle: Amino acid metabolic pathways altered in cancer and select inhibitors targeting
  these pathways
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7463463
filename: cells-09-01904-g001.jpg
figlink: pmc/articles/PMC7463463/figure/cells-09-01904-f001/
number: F1
caption: 'Amino acid metabolic pathways altered in cancer and select inhibitors targeting
  these pathways. (A) Three main amino acid transporters (AATs) upregulated in cancer
  cells and transporter-targeting inhibitors that are either being used clinically
  or tested in clinical trials are shown. (B) A simplified macropinocytosis process
  is depicted and inhibitors targeting the process are shown. Rat sarcoma virus oncogene
  homolog (Ras) and phosphatidylinositol-3-kinases (PI3Ks) positively regulate macropinocytosis
  by promoting Rac1 and Cdc42-mediated actin polymerization. (C) Kynurenine is a catabolite
  derived from tryptophan. Key enzymes in the kynurenine synthesis pathway, regulatory
  mechanisms of kynurenine, and IDO/TDO inhibitors tested in clinical trials are shown.
  (D) Polyamines are catabolites derived from arginine. Polyamine synthesis and catabolic
  pathways are depicted, and polyamine metabolism inhibitors tested in clinical trials
  are shown. Metabolites are in grey, proteins are in blue, and inhibitors are in
  black. Proteins: ASCT2: Alanine-serine-cysteine transporters 2; LAT1: L-type amino
  acid transporter 1; xCT/CD98hc: 4FC2 cystine/glutamate heterodimeric antiporter;
  GLS: Glutaminase; GS: Glutamine synthetase; NHE: Na+/H+ exchanger; Rac1: Ras-related
  C3 botulinum toxin substrate 1; Cdc42: Cell division control protein 42; PAK1: P21-activate
  kinase 1; PI3K: Phosphoinositide 3-kinases; IDO1/2: Indoleamine-2,3-dioxygenase
  1,2; TDO: Tryptophan-2,3-dioxygenase; AFMID: Kynurenine formamidase; AhR: Aryl hydrocarbon
  receptor; ARNT: Aryl hydrocarbon receptor nuclear translocator; ARG: Arginase; ODC:
  Ornithine decarboxylase; AMD1: S-adenosylmethionine decarboxylase 1; SPDSY: Spermidine
  synthase; SPMSY: Spermine synthase; SAT1: Spermidine/spermine N1-acetyltransferase;
  PAO: Polyamine oxidase. Metabolites: Cys-Cys: Cystine; Cys: Cysteine; Gly: Glycine;
  Glu: Glutamate; Gln: Glutamine; Neutral AAs: Neutral amino acids (alanine, serine,
  cysteine, glutamine); BCAAs: Branched-chain amino acid (valine, leucine, isoleucine);
  bulky AAs: Bulky amino acids (phenylalanine, methionine, histidine, tryptophan,
  tyrosine); Trp: Tryptophan; N’-formylkyn: N’-formylkynurenine; Kyn: Kynurenine;
  Cit: Citrulline; Arg: Arginine; Orn: Ornithine; SAM: S-adenosylmethionine; dcSAM:
  Decarboxylated. Cells: Th: T-helper cell; Treg: Regulatory T cell. Inhibitors: DFMO:
  Difluoromethylornithine.'
papertitle: Oncology Therapeutics Targeting the Metabolism of Amino Acids.
reftext: Nefertiti Muhammad, et al. Cells. 2020 Aug;9(8):1904.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.968123
figid_alias: PMC7463463__F1
figtype: Figure
redirect_from: /figures/PMC7463463__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7463463__cells-09-01904-g001.html
  '@type': Dataset
  description: 'Amino acid metabolic pathways altered in cancer and select inhibitors
    targeting these pathways. (A) Three main amino acid transporters (AATs) upregulated
    in cancer cells and transporter-targeting inhibitors that are either being used
    clinically or tested in clinical trials are shown. (B) A simplified macropinocytosis
    process is depicted and inhibitors targeting the process are shown. Rat sarcoma
    virus oncogene homolog (Ras) and phosphatidylinositol-3-kinases (PI3Ks) positively
    regulate macropinocytosis by promoting Rac1 and Cdc42-mediated actin polymerization.
    (C) Kynurenine is a catabolite derived from tryptophan. Key enzymes in the kynurenine
    synthesis pathway, regulatory mechanisms of kynurenine, and IDO/TDO inhibitors
    tested in clinical trials are shown. (D) Polyamines are catabolites derived from
    arginine. Polyamine synthesis and catabolic pathways are depicted, and polyamine
    metabolism inhibitors tested in clinical trials are shown. Metabolites are in
    grey, proteins are in blue, and inhibitors are in black. Proteins: ASCT2: Alanine-serine-cysteine
    transporters 2; LAT1: L-type amino acid transporter 1; xCT/CD98hc: 4FC2 cystine/glutamate
    heterodimeric antiporter; GLS: Glutaminase; GS: Glutamine synthetase; NHE: Na+/H+
    exchanger; Rac1: Ras-related C3 botulinum toxin substrate 1; Cdc42: Cell division
    control protein 42; PAK1: P21-activate kinase 1; PI3K: Phosphoinositide 3-kinases;
    IDO1/2: Indoleamine-2,3-dioxygenase 1,2; TDO: Tryptophan-2,3-dioxygenase; AFMID:
    Kynurenine formamidase; AhR: Aryl hydrocarbon receptor; ARNT: Aryl hydrocarbon
    receptor nuclear translocator; ARG: Arginase; ODC: Ornithine decarboxylase; AMD1:
    S-adenosylmethionine decarboxylase 1; SPDSY: Spermidine synthase; SPMSY: Spermine
    synthase; SAT1: Spermidine/spermine N1-acetyltransferase; PAO: Polyamine oxidase.
    Metabolites: Cys-Cys: Cystine; Cys: Cysteine; Gly: Glycine; Glu: Glutamate; Gln:
    Glutamine; Neutral AAs: Neutral amino acids (alanine, serine, cysteine, glutamine);
    BCAAs: Branched-chain amino acid (valine, leucine, isoleucine); bulky AAs: Bulky
    amino acids (phenylalanine, methionine, histidine, tryptophan, tyrosine); Trp:
    Tryptophan; N’-formylkyn: N’-formylkynurenine; Kyn: Kynurenine; Cit: Citrulline;
    Arg: Arginine; Orn: Ornithine; SAM: S-adenosylmethionine; dcSAM: Decarboxylated.
    Cells: Th: T-helper cell; Treg: Regulatory T cell. Inhibitors: DFMO: Difluoromethylornithine.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD98hc
  - Nhe3
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ras
  - Ras64B
  - Ras85D
  - Pak
  - Cys
  - mmy
  - Csp
  - na
  - Rac1
  - Rac2
  - Cdc42
  - gs
  - sam
  - qkr54B
  - sls
  - Sam-S
  - .na.character
  - om
  - CycE
  - cyc
  - arg
  - aos
  - ss
  - FGD1
  - SLC3A2
  - SLC9C1
  - SLC7A11
  - SLC7A5
  - LAT
  - SLC1A5
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - PAK1
  - PKN1
  - RAC1
  - RNASE1
  - CDC42
  - GNAS
  - GNAL
  - ST3GAL5
  - SMS
  - SMOX
  - PAOX
  - SAT1
  - SLC26A1
  - SLC38A1
  - AFMID
  - ID2
  - ODC1
  - SLC25A21
  - DLX3
  - TDO2
  - ABL2
  - RERE
  - AHR
  - sulfasalazine
  - Sorafenib
  - EIPA
  - Imipramine
  - Cys-Cys
  - 4F2C
  - Glu
  - Cys
  - Na
  - GSH
  - Amino acids
  - Polyamines
  - Spermine
  - AcetylSpermine
  - Spermidine
  - AcetylSpermidine
  - Nformyl
  - Putrescine
  - BMS986205
  - DFMOH ODC
  - Trp
  - Arg
  - ARG
  - Argininosuccinate
  - GS
  - Aggressiveness
---
